ASK A DOCTOR
Question
  • Is it safety for Natrelle Breast Implants in Philadelphia

    Asked by Jaden Jenna, 2024-07-01 19:26:48
    1 Answers

    Has anyone figured it out?

Answer
  • Answered by Jordan Laura, 02/07/2024 07:05

    As a plastic surgeon in Philadelphia, I can provide you with an overview of the safety considerations regarding Natrelle breast implants.

    Natrelle breast implants are a type of silicone-filled implant manufactured by Allergan, a leading medical device company. These implants have been approved by the U.S. Food and Drug Administration (FDA) for breast augmentation and reconstruction procedures. While breast implants, in general, carry certain risks, Natrelle implants have been extensively studied and have demonstrated a good safety profile when used for appropriate candidates and with proper surgical techniques.

    One of the primary concerns with breast implants is the potential for complications, such as capsular contracture, rupture, or the development of a rare type of cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Regarding Natrelle implants, the overall complication rates have been found to be consistent with those observed with other silicone-filled breast implants.

    Capsular contracture, which is the tightening or hardening of the scar tissue around the implant, is one of the most common complications associated with breast implants. The reported rates of capsular contracture with Natrelle implants are within the expected range for silicone-filled implants, typically ranging from 5% to 10% over a 10-year period.

    Implant rupture is another potential complication, and the FDA-approved rupture rate for Natrelle implants is less than 1% over a 10-year period. In the event of a rupture, the silicone gel typically remains contained within the implant shell or the surrounding scar tissue, minimizing the risk of silicone migration or other systemic effects.

    Regarding BIA-ALCL, this rare type of lymphoma has been associated with textured breast implants, including some Natrelle models. However, the risk remains extremely low, with an estimated incidence of 1 in 30,000 to 1 in 300,000 women with textured breast implants. It is important to note that the FDA has not recommended the removal of textured breast implants in the absence of symptoms or other complications.

    When considering Natrelle breast implants in Philadelphia, it is crucial to work with an experienced and board-certified plastic surgeon who can thoroughly evaluate your individual needs, discuss the potential risks and benefits, and guide you through the decision-making process. Proper patient selection, surgical technique, and ongoing monitoring are essential to ensuring the best possible outcomes and minimizing the risk of complications.

    In summary, Natrelle breast implants have demonstrated a good safety profile when used by qualified plastic surgeons. While no surgical procedure is without risk, the benefits of breast augmentation or reconstruction with Natrelle implants often outweigh the potential complications for many patients. By working closely with a trusted plastic surgeon, you can make an informed decision and achieve your desired aesthetic goals safely and effectively.

STAY IN TOUCH

Get updated with beauty resources, tips, and news

Discover safe and empowering ways to enhance your beauty with our informative and joyful resources

Subscription